progscrape: med.umn.edu

First-in-human clinical trial testing CRISPR/Cas9 gene-editing in 12 highly metastatic, end-stage GI cancer patients saw several of their cancer growth halt, and one patient had a complete response - metastatic tumors disappeared over course of several months and have not returned in over two years.

8 hours ago med.umn.edu cancer trial

Study links long-term artificial sweetener intake to increased body fat adipose tissue volume

21 months ago med.umn.edu health

New antifungal therapy for fungal meningitis

20 months ago med.umn.edu

Sticking With The Wrong Choice - People remain committed to a choice, even when a clear alternate choice is better, because of time, effort, or money already invested - a cognitive phenomenon known as the “sunk cost fallacy”

6 years ago med.umn.edu